Business Standard

Sunday, December 22, 2024 | 06:55 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Pfizer's Covid-19 vaccine may cost less than $10 a dose in India

Govt likely to give partial indemnity to company

Pfizer vaccine,
Premium

Pfizer is now in discussions with the Indian government for supplying the vaccine

Sohini Das Mumbai
US pharmaceutical major Pfizer may price its mRNA-based Covid-19 vaccine, co-developed by BioNTech, below $10 (about Rs 730) a dose in India, sources close to the development indicated. This could be the lowest price of the vaccine globally, and almost half the price in developed markets like the US, UK, and EU.

“It is a single-digit price per dose,” a source said. “This is a not-for-profit price for the government’s immunisation programme.”

Pfizer is now in discussions with the Indian government for supplying the vaccine. “Pfizer has offered to make the required doses of our Covid-19 vaccine available at a

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in